Strain differences in the effects of adrenalectomy on the midbrain dopamine system: implication for behavioral sensitization to cocaine

Neuroscience
Inge E M de JongE Ronald de Kloet

Abstract

Adrenalectomy (ADX) abolishes behavioral sensitization to cocaine in DBA/2, but not C57BL/6 inbred mice. The present study tests the hypothesis that this ADX effect on behavioral sensitization in the DBA/2 strain involves changes in midbrain dopamine systems that do not occur in the C57BL/6 strain. For that purpose, we have measured tyrosine hydroxylase (TH) and dopamine transporter (DAT) mRNA and D1- and D2-like receptor binding in C57BL/6 and DBA/2 mice that were i) unoperated, ii) ADX or sham (SHAM) operated, or iii) ADX or SHAM operated and subjected to a cocaine sensitization regimen (15.0 mg/kg cocaine on nine consecutive days, followed by a 7.5 mg/kg challenge after a 5-day withdrawal). ADX prevented behavioral sensitization to cocaine in the DBA/2, but not the C57BL/6 strain [de Jong IEM, Oitzl MS, de Kloet ER (2007) Adrenalectomy prevents behavioural sensitisation of mice to cocaine in a genotype-dependent manner. Behav Brain Res 177:329-339]. Mice were killed under basal conditions, in the latter case 24 h after the cocaine challenge. ADX did not affect the dopaminergic markers in drug naïve mice. By contrast, strain-dependent neuroadaptations were found in the midbrain dopamine system of mice subjected to the sensiti...Continue Reading

References

Jul 1, 1990·Pharmacology, Biochemistry, and Behavior·S J Yi, K M Johnson
Jul 1, 1990·Pharmacology, Biochemistry, and Behavior·N ShanksH Anisman
Apr 1, 1995·Pharmacology, Biochemistry, and Behavior·C J MeliskaR A Jensen
Dec 24, 1996·Proceedings of the National Academy of Sciences of the United States of America·P V PiazzaM Le Moal
Apr 1, 1997·Progress in Neurobiology·S Puglisi-Allegra, S Cabib
Nov 5, 1998·Psychoneuroendocrinology·B C JonesP Mormède
Apr 13, 2000·The European Journal of Neuroscience·M BarrotP V Piazza
Jul 7, 2001·Neuroscience·R VenturaS Puglisi-Allegra
May 23, 2002·The Journal of Pharmacology and Experimental Therapeutics·Nick E Goeders
Aug 24, 2002·The European Journal of Neuroscience·Michela Marinelli, Pier Vincenzo Piazza
Sep 12, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Rossella VenturaStefano Puglisi-Allegra
Nov 1, 1958·The Anatomical Record·K P HUMMEL
Jan 21, 2004·The Pharmacogenomics Journal·J ErblichD H Bovbjerg
Mar 17, 2004·Current Opinion in Pharmacology·Peter W Kalivas
Oct 29, 2005·European Journal of Pharmacology·Bart A EllenbroekAlexander R Cools
Dec 8, 2006·Behavioural Brain Research·Inge E M de JongE Ronald de Kloet
Feb 6, 2007·Journal of Chemical Neuroanatomy·Loredana D'EsteTindaro G Renda

❮ Previous
Next ❯

Citations

Jun 3, 2014·Brain Research·Glenn F GuerinNicholas E Goeders
Jul 15, 2015·Behavioural Pharmacology·Vincent DidoneEtienne Quertemont
Jun 23, 2011·Neurochemistry International·Joanna SolichMarta Dziedzicka-Wasylewska
Feb 28, 2020·Brain Sciences·Simona CabibStefano Puglisi-Allegra
Nov 2, 2019·Neuroscience and Biobehavioral Reviews·Erik H Douma, E Ronald de Kloet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.